Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population.
Testi I, Agrawal R, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M, Chee SP, Mccluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham ET, Kempen JH, Nguyen QD, Pavesio C, Gupta V. Testi I, et al. Among authors: esposti sd. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):58-64. doi: 10.1080/09273948.2020.1781197. Epub 2020 Aug 17. Ocul Immunol Inflamm. 2020. PMID: 32804578
Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation.
Carelli V, Newman NJ, Yu-Wai-Man P, Biousse V, Moster ML, Subramanian PS, Vignal-Clermont C, Wang AG, Donahue SP, Leroy BP, Sergott RC, Klopstock T, Sadun AA, Rebolleda Fernández G, Chwalisz BK, Banik R, Girmens JF, La Morgia C, DeBusk AA, Jurkute N, Priglinger C, Karanjia R, Josse C, Salzmann J, Montestruc F, Roux M, Taiel M, Sahel JA; the LHON Study Group. Carelli V, et al. Ophthalmol Ther. 2023 Feb;12(1):401-429. doi: 10.1007/s40123-022-00611-x. Epub 2022 Nov 30. Ophthalmol Ther. 2023. PMID: 36449262 Free PMC article.
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.
Popat R, Lonial S, Voorhees PM, Esposti SD, Gorsh B, Gupta I, Opalinska J, Sapra S, Piontek T, He Z, Kleinman D, Schaumberg D, Regnault A, Meunier J, Eliason L. Popat R, et al. Among authors: esposti sd. J Adv Pract Oncol. 2023 Sep;14(6):503-518. doi: 10.6004/jadpro.2023.14.6.4. Epub 2023 Sep 1. J Adv Pract Oncol. 2023. PMID: 37808071 Free PMC article.
Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.
Agrawal R, Gunasekeran DV, Grant R, Agarwal A, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study (COTS)–1 Study Group. Agrawal R, et al. JAMA Ophthalmol. 2017 Dec 1;135(12):1318-1327. doi: 10.1001/jamaophthalmol.2017.4485. JAMA Ophthalmol. 2017. PMID: 29075752 Free PMC article.
The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends.
Agarwal A, Agrawal R, Gunasekaran DV, Raje D, Gupta B, Aggarwal K, Murthy SL, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham E, Nguyen QD, Pavesio C, Gupta V. Agarwal A, et al. Ocul Immunol Inflamm. 2019;27(3):465-473. doi: 10.1080/09273948.2017.1406529. Epub 2017 Dec 20. Ocul Immunol Inflamm. 2019. PMID: 29261089 Free article.
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis.
Agrawal R, Gunasekeran DV, Agarwal A, Carreño E, Aggarwal K, Gupta B, Raje D, Murthy SI, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Lord J, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Kempen J, Cunningham ET, Rousselot A, Nguyen QD, Pavesio C, Gupta V. Agrawal R, et al. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):38-48. doi: 10.1080/09273948.2018.1489061. Epub 2018 Aug 29. Ocul Immunol Inflamm. 2020. PMID: 30156979
Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1.
Testi I, Agrawal R, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M, Chee SP, McCluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Rousselot A, Grant R, Kon OM, Cunningham ET, Kempen J, Nguyen QD, Pavesio C, Gupta V. Testi I, et al. Among authors: esposti sd. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):8-16. doi: 10.1080/09273948.2019.1646774. Epub 2019 Nov 25. Ocul Immunol Inflamm. 2020. PMID: 31763952
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis.
Agarwal A, Agrawal R, Raje D, Testi I, Mahajan S, Gunasekeran DV, Aggarwal K, Murthy SI, Westcott M, Chee SP, Mccluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham ET, Kempen JH, Nguyen QD, Pavesio C, Gupta V. Agarwal A, et al. Among authors: esposti sd. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):65-73. doi: 10.1080/09273948.2020.1761401. Epub 2020 Jun 26. Ocul Immunol Inflamm. 2020. PMID: 32589551
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis.
Agrawal R MD FCRS, Betzler B MBBS, Testi I MD, Mahajan S MBBS, Agarwal A MS, Gunasekeran DV MD, Raje D PhD, Aggarwal K MS, Murthy SI DNB, Westcott M FRCSOphth, Chee SP FRCSEd, Mccluskey P MD, Ho SL FRCSGlasg, Teoh S FRCSEd, Cimino L MD, Biswas J MS, Narain S MD, Agarwal M MS, Mahendradas P DNB, Khairallah M MD, Jones N FRCSOphth, Tugal-Tutkun I MD, Babu K DNB, Basu S MS, Carreño E MD, Lee R PhD, Al-Dhibi H MD, Bodaghi B MD, Invernizzi A MD, Goldstein DA MD, Herbort CP MD, Barisani-Asenbauer T PhD, González-López JJ PhD, Androudi S MD, Bansal R MS, Moharana B MS, Esposti S MD, Tasiopoulou A MD, Nadarajah S MD, Agarwal M DNB, Abraham S MD, Vala R MD, Singh R MS, Sharma A MD, Sharma K PhD, Zierhut M PhD, Kon OM MRCP, Cunningham ET PhD, Kempen JH PhD, Nguyen QD PhD, Pavesio C FRCSOphth, Gupta V MS. Agrawal R MD FCRS, et al. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):17-26. doi: 10.1080/09273948.2020.1761400. Epub 2020 Jun 30. Ocul Immunol Inflamm. 2020. PMID: 32600163
Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6.
Agrawal R MD, FCRS, Gunasekeran DV MBBS, Agarwal A MS, Testi I MD, Carreño E MD, Westcott M FRCOphth, Mahajan S MBBS, Raje D PhD, Aggarwal K MS, Murthy SI DNB, Chee SP FRCSEd, Mccluskey P MD, Ho SL FRCSGlasg, Teoh S FRCSEd, Cimino L MD, Biswas J MS, Narain S MD, Agarwal M MS, Mahendradas P DNB, Khairallah M MD, Jones N FRCSOphth, Tugal-Tutkun I MD, Babu K DNB, Basu S MS, Lee R PhD, Al-Dhibi H MD, Bodaghi B MD, Invernizzi A MD, Goldstein DA MD, Herbort CP MD, Barisani-Asenbauer T PhD, González-López JJ PhD, Androudi S MD, Bansal R MS, Moharana B MS, Esposti SD MD, Tasiopoulou A MD, Nadarajah S MD, Agarwal M DNB, Abraham S MD, Vala R MD, Singh R MS, Sharma A MD, Sharma K PhD, Zierhut M PhD, Kon OM MRCP, Cunningham ET PhD, Kempen JH PhD, Nguyen QD PhD, Pavesio C FRCSOphth, Gupta V MS. Agrawal R MD, FCRS, et al. Among authors: esposti sd md. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):49-57. doi: 10.1080/09273948.2020.1774905. Epub 2020 Jun 30. Ocul Immunol Inflamm. 2020. PMID: 32600169
43 results